Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvant

[1]  J. O'dell,et al.  Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis. , 2012, International immunopharmacology.

[2]  Ida E. Andersson,et al.  Multifunctional T cell reactivity with native and glycosylated type II collagen in rheumatoid arthritis. , 2012, Arthritis and rheumatism.

[3]  R. Toes,et al.  Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. , 2012, The Journal of clinical investigation.

[4]  Ji Young Han,et al.  Effect of anti-rheumatic agents on periodontal parameters and biomarkers of inflammation: a systematic review and meta-analysis , 2012, Journal of periodontal & implant science.

[5]  G. Kollias,et al.  Regulatory T Cells Protect from Local and Systemic Bone Destruction in Arthritis , 2010, The Journal of Immunology.

[6]  D. M. van der Heijde,et al.  The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis , 2010, Annals of the rheumatic diseases.

[7]  G. Verbruggen,et al.  A multiparameter approach to monitor disease activity in collagen-induced arthritis , 2010, Arthritis research & therapy.

[8]  Kutty Selva Nandakumar,et al.  Antibodies to citrullinated proteins: molecular interactions and arthritogenicity , 2010, Immunological reviews.

[9]  J. Berthelot,et al.  A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis , 2009, Arthritis research & therapy.

[10]  D. Heijde,et al.  Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study , 2009, Annals of the rheumatic diseases.

[11]  T. Huizinga,et al.  Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. , 2008, Arthritis and rheumatism.

[12]  J. Smolen,et al.  CTLA-4 directly inhibits osteoclast formation , 2008, Annals of the rheumatic diseases.

[13]  M. Sebbag,et al.  Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. , 2007, Arthritis and rheumatism.

[14]  Georg Schett,et al.  Cytokines in the pathogenesis of rheumatoid arthritis , 2007, Nature Reviews Immunology.

[15]  M. Silva,et al.  IKKβ inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis , 2006 .

[16]  M. Silva,et al.  Application of Surface Roughness Analysis on Micro–Computed Tomographic Images of Bone Erosion: Examples Using a Rodent Model of Rheumatoid Arthritis , 2006, Molecular imaging.

[17]  J. Risteli,et al.  Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis? , 2005, Annals of the rheumatic diseases.

[18]  A. Suzuki,et al.  Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis. , 2005, Biochemical and biophysical research communications.

[19]  A. Boskey,et al.  Bone Fragility and Collagen Cross‐Links , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  T. Meert,et al.  Bone cancer pain model in mice: evaluation of pain behavior, bone destruction and morphine sensitivity , 2004, Pharmacology Biochemistry and Behavior.

[21]  H. Hagino,et al.  Effect of minodronic acid (ONO-5920) on bone mineral density and arthritis in adult rats with collagen-induced arthritis. , 2003, Arthritis and rheumatism.

[22]  E. Schwarz,et al.  Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. , 2002, Arthritis and rheumatism.

[23]  M. Ito,et al.  Stage-dependent changes in trabecular bone turnover and osteogenic capacity of marrow cells during development of type II collagen-induced arthritis in mice. , 2002, Bone.

[24]  T S Smith,et al.  Three‐dimensional microimaging (MRμI and μCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis , 2001, The Anatomical record.

[25]  A Odgaard,et al.  Three-dimensional methods for quantification of cancellous bone architecture. , 1997, Bone.

[26]  L. Klareskog,et al.  Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement , 1991, Journal of Autoimmunity.

[27]  O. Akkus,et al.  Local variations in the micromechanical properties of mouse femur: the involvement of collagen fiber orientation and mineralization. , 2007, Journal of biomechanics.

[28]  BMC Medical Imaging BioMed Central , 2004 .

[29]  TOR Hildebrand,et al.  Quantification of Bone Microarchitecture with the Structure Model Index. , 1997, Computer methods in biomechanics and biomedical engineering.

[30]  M. Murphey,et al.  Measurement of radiographic changes in adjuvant-induced arthritis in rats by quantitative image analysis. , 1995, Arthritis and rheumatism.

[31]  P. Wooley.  [33] Collagen-induced arthritis in the mouse , 1988 .